Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre Study for Evaluation of the Efficacy and Safety of Buprenorphine Transdermal Patch (SOVENOR®) 5mg and 10mg in Patients With Non-malignant Pain of Moderate Intensity Due to Osteoarthritis, Rheumatoid Arthritis, Lower Back Pain and Joint/Muscle Pain, When an Opioid is Necessary for Obtaining Adequate Analgesia

NCT02519387 is registered in ClinicalTrials.gov with Mundipharma Pharmaceuticals Sdn. Bhd. as lead sponsor.

NCT NCT02519387
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02519387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre Study for Evaluation of the Efficacy and Safety of Buprenorphine Transdermal Patch (SOVENOR®) 5mg and 10mg in Patients With Non-malignant Pain of Moderate Intensity Due to Osteoarthritis, Rheumatoid Arthritis, Lower Back Pain and Joint/Muscle Pain, When an Opioid is Necessary for Obtaining Adequate Analgesia
Lead sponsor
Mundipharma Pharmaceuticals Sdn. Bhd.
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2013
Completion date
January 31, 2015
Enrollment
78 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

joint pain, lower back pain, muscle pain, osteoarthritis, rheumatoid arthritis